Cartesian Therapeutics, Inc.(RNAC)
Biotechnology
Cell Therapy (CAR-T, etc.)
| Filing Date | Insider | Type | 10b5-1 | Net Shares | Ownership change | Avg. Price | Value | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-01-08 | Brunn Carsten President and CEO | Sale | -23,766 | -6.84%323,530 | $6.82 | $162,077 | View SEC filing | |
| 2026-01-08 | Miljkovic Milos Chief Medical Officer | Sale | -3,573 | -5.73%58,820 | $6.82 | $24,367 | View SEC filing | |
| 2026-01-08 | Davis Blaine Chief Financial Officer | Sale | -10,591 | -8.03%121,220 | $6.82 | $72,227 | View SEC filing | |
| 2025-12-08 | BARABE TIMOTHY C Director | Purchase | +30,000 | +123.12%54,366 | $6.86 | $205,797 | View SEC filing | |
| 2025-04-11 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +149,075 | +1.63%9,300,198 | $10.21 | $1,522,517 | View SEC filing | |
| 2025-03-20 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +89,863 | +1.05%8,621,325 | $15.26 | $1,371,154 | View SEC filing | |
| 2025-01-15 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +20,967 | +0.25%8,531,462 | $17.47 | $366,354 | View SEC filing | |
| 2025-01-07 | Kurtoglu Metin Chief Technology Officer | Sale | -4,875 | -7.26%62,258 | $16.78 | $81,790 | View SEC filing | |
| 2025-01-07 | Miljkovic Milos Chief Medical Officer | Sale | -1,880 | -5.04%35,393 | $16.78 | $31,542 | View SEC filing | |
| 2025-01-07 | Jewell Christopher M Chief Scientific Officer | Sale | -2,550 | -4.55%53,490 | $16.78 | $42,783 | View SEC filing | |
| 2025-01-07 | English Emily Chief Operations Officer | Sale | -1,797 | -4.28%40,226 | $16.78 | $30,149 | View SEC filing | |
| 2025-01-07 | Brunn Carsten President and CEO | Sale | -17,271 | -7.80%204,096 | $16.78 | $289,764 | View SEC filing | |
| 2025-01-07 | Davis Blaine Chief Financial Officer | Sale | -7,989 | -7.77%94,811 | $16.78 | $134,036 | View SEC filing | |
| 2024-12-23 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +52,189 | +0.62%8,507,895 | $18.49 | $965,021 | View SEC filing | |
| 2024-12-11 | Kurtoglu Metin Chief Technology Officer | Sale | -13,664 | -17.42%51,033 | $25.26 | $345,134 | View SEC filing | |
| 2024-11-21 | Kurtoglu Metin Chief Technology Officer | Sale | -38,689 | -0.39%51,033 | $16.78 | $649,030 | View SEC filing | |
| 2024-11-18 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +431,940 | +5.38%8,455,706 | $17.07 | $7,373,527 | View SEC filing | |
| 2024-11-18 | Kurtoglu Metin Chief Technology Officer | Sale | -82,368 | -33.67%51,033 | $17.46 | $1,438,038 | View SEC filing | |
| 2024-11-18 | Miljkovic Milos Chief Medical Officer | Sale | -55,000 | -65.70%18,273 | $16.50 | $907,533 | View SEC filing | |
| 2024-11-18 | Jewell Christopher M Chief Scientific Officer | Sale | -52,115 | -58.15%25,940 | $16.79 | $875,042 | View SEC filing | |
| 2024-10-04 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +205,721 | +2.63%8,023,766 | $20.87 | $4,293,545 | View SEC filing | |
| 2024-08-14 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +8,016 | +229.49%11,509 | $12.72 | $101,968 | View SEC filing | |
| 2024-08-14 | BARABE TIMOTHY C Director | Purchase | +7,500 | +52.57%21,766 | $12.70 | $95,250 | View SEC filing | |
| 2024-03-28 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +18,400 | +21.29%104,818 | $0.62 | $11,442 | View SEC filing | |
| 2024-03-20 | SPRINGER TIMOTHY A Director, 10% Owner | Purchase | +19,044 | +0.06%31,073,406 | $0.60 | $11,398 | View SEC filing |
1-25 of 121